FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to a phthisiology, in particular to the use of an o-benzoylaminobenzoic acid derivative of formula I: (I) as an anti-tuberculosis agent, having bacteriostatic activity with respect to M. tuberculosis strains H37Rv and MS-115.
EFFECT: invention provides extending the range of anti-tuberculosis drugs.
1 cl, 4 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
Authors
Dates
2019-03-29—Published
2018-02-26—Filed